1 厉宣英,何君梅.高危型HPV DNA负荷量在预测CINⅠ转归可能性中的价值.潍坊医学院学报,2015,37:300-302.
2 张博,张颖,牛力春,等.液基细胞学联合HPVmRNA检测对宫颈癌的诊断价值.现代肿瘤医学,2016,24:118-122.
3 Li T,Tang L,Bian D,et al.Detection of hTERC and c-MYC genes in cervical epithelial exfoliated cells for cervical cancer screening.Int J Mol Med,2014,33:1289-1297.
4 李亚波,杨隽,丁世霖,等.人乳头瘤病毒、端粒酶基因及3号染色体数目与宫颈病变关系的探讨.国际检验医学杂志,2016,37:326-328.
5 齐丽敏,杨青,冯晔,等.TCT联合HPV及hTERC、HER-2和c-myc基因在宫颈高度病变筛查中的价值研究.现代肿瘤医学,2015,23:2180-2183.
6 Pileggi C,Flotta D,Bianco A,et al.Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized con-trolled trials.Int J Cancer,2014,135:166-177.
7 季雯婷,楼微华,洪祖蓓,等.TCT、HPV、h-TERC基因和c-MYC基因联合检测在宫颈疾病筛查中应用价值研究.现代妇产科进展,2014,23:105-108,112.
8 Kusy M,Obrzut B,Kluska J.Application of gene expression pro-gramming and neural networks to predict adverse events of radical hysterectomy in cervical cancer patients.Med Biol Eng Comput,2013,51:1357-1365.
9 钱敏,姚芳芳,尤志学,等.宫颈脱落细胞中HPVL1壳蛋白的表达及临床意义.中国妇产科临床杂志,2013,14:30-33.
10 吴丹梅,陈曼玲,金松.TCT HPV及hTERC基因检测在宫颈癌筛查中的临床价值.重庆医学,2013,42:4185-4187.
11 马玉兰,玛依努尔·尼牙孜,张海萌,等.HPVL1壳蛋白与hTERC基因联合检测诊断新疆维、汉妇女宫颈病变CIN2+的临床价值.现代生物医学进展,2016,16:1281-1284,1340.
